Serbanica, A.N.; Popa, D.C.; Caruntu, C.; Pasca, S.; Scheau, C.; Serbanica, I.V.; Suciu, R.; Tica, V.; Busescu, E.; Cima, L.N.;
et al. The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia. J. Clin. Med. 2023, 12, 1451.
https://doi.org/10.3390/jcm12041451
AMA Style
Serbanica AN, Popa DC, Caruntu C, Pasca S, Scheau C, Serbanica IV, Suciu R, Tica V, Busescu E, Cima LN,
et al. The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Medicine. 2023; 12(4):1451.
https://doi.org/10.3390/jcm12041451
Chicago/Turabian Style
Serbanica, Andreea Nicoleta, Delia Codruta Popa, Constantin Caruntu, Sergiu Pasca, Cristian Scheau, Ionut Vlad Serbanica, Raluca Suciu, Valeria Tica, Elisa Busescu, Luminita Nicoleta Cima,
and et al. 2023. "The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia" Journal of Clinical Medicine 12, no. 4: 1451.
https://doi.org/10.3390/jcm12041451
APA Style
Serbanica, A. N., Popa, D. C., Caruntu, C., Pasca, S., Scheau, C., Serbanica, I. V., Suciu, R., Tica, V., Busescu, E., Cima, L. N., Jardan, C., Dragomir, M., Coriu, D., Colita, A., & Colita, A.
(2023). The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Medicine, 12(4), 1451.
https://doi.org/10.3390/jcm12041451